Here Is Why EXACT Sciences Corporation Has Crashed

Exact Sciences Corp. (NASDAQ:EXAS) stock has been tumbling today, after the US Preventive Services Task Force (USPSTF) issued a recommendation statement about the company's key product, Cologuard, which is a stool test of colon cancer. The company's shares crashed more than 46% today.